Life Technologies Quantstudio 7 Flex Real-Time PCR (qPCR) Service Agreement (“AB Assurance” or equal plan), Base Year plus two options

The FDA's National Center for Toxicological Research seeks a preventative maintenance and unlimited repair service agreement for a Life Technologies QuantStudio 7 Flex Real-Time PCR instrument, with quotes due June 23, 2026 at 3:30 PM Central Time. The procurement is firm fixed price with no set-aside restriction.

Place of performance is Jefferson, Arkansas. The service agreement covers a base year plus two option years, with performance running August 15, 2026 through August 14, 2029. Required services include one annual preventative maintenance inspection, calibration and temperature verification of optical and mechanical blocks, software updates, cleaning and alignment of optical and mechanical systems, functional testing, and performance verification. The contractor must guarantee priority response within two business days of a service call, with scheduled and emergency service available Monday through Friday, 8:00 AM to 5:00 PM (excluding federal holidays). All work must be performed by OEM-trained and certified technicians using OEM-specified materials, manuals, and service bulletins.

The NAICS code is 811210, Electronic and Precision Equipment Repair and Maintenance ($34 million size standard). PSC is J066. Contractors must certify compliance with Service Contract Act exemption requirements under FAR 52.222-48 and provide evidence of relevant experience with this specific equipment model within the past three years. Quotes must be submitted by email to Suzanne Martella (suzanne.martella@fda.hhs.gov) and reference solicitation number 75F40126Q132996. Evaluation weighs technical capability, past performance, and price, with non-price factors weighted equally and collectively more important than price. Invoices must be submitted electronically through Treasury's Invoice Processing Platform with Net 30 payment terms following government acceptance.